Navigation Links
New Chemo Drug May Benefit Some Breast Cancer Patients
Date:3/2/2011

WEDNESDAY, March 2 (HealthDay News) -- The new chemotherapy drug eribulin extends the lives of metastatic breast cancer patients who have received extensive treatment, according to a new study.

The researchers found that among patients whose cancer had spread, those who took the drug lived a median of 2.5 months longer than those who received a physician-chosen treatment -- 13.1 months versus 10.6 months.

The study included 508 women who were given eribulin and 254 women who received treatment of the physician's choice, which was defined as: any single-agent chemotherapy, hormonal or biological treatment approved for cancer treatment; radiotherapy; or symptomatic treatment alone.

The most common side effects in both groups were fatigue and depletion of white blood cells. Numbness and pain stemming from nerve damage were the most common adverse event connected to eribulin that led women to drop out of the study (24, or 5 percent).

The study, known as the EMBRACE trial, was funded by Eisai Inc., which markets eribulin. Dr. Javier Cortes, of the Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology in Barcelona, Spain, and colleagues published the findings in the March 3 online edition of The Lancet.

"This global phase 3 study establishes a potential new standard treatment for women with heavily pretreated metastatic breast cancer, for whom there was previously no chemotherapy treatment with proven survival benefit," the authors wrote.

In a related editorial, Drs. Nancy U. Lin and Harold J. Burstein, of the Dana-Farber Cancer Institute and Harvard Medical School in Boston, said: "EMBRACE provides much needed, high-level evidence for chemotherapy use in patients with heavily pretreated breast cancer. And that evidence suggests that the methods to treat advanced breast cancer are growing, the treatment challenge in refractory disease is a little bit less daunting, and the treatmen
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. BUSM study shows chemoradiotherapy prior to surgery improves survival
2. Fish oil fights weight loss due to chemotherapy
3. Pot Ingredient May Restore Appetite After Chemo
4. Intensive chemotherapy can dramatically boost survival of older teenage leukemia patients
5. Stray Breast Tumor Cells in Early Chemo Could Be Bad Sign
6. Phase III efficacy data on bevacizumab plus chemotherapy in early breast cancer to be presented
7. Adding ipilimumab to standard chemotherapy treatment for late-stage lung cancer may improve survival
8. Surgery complications linked to chemotherapy delay, U-M study finds
9. Breast cancer: Reducing the risk of unnecessary chemo
10. Combining radiation therapy, chemotherapy safely treats head and neck cancer patients
11. Newer, more intense chemotherapy with less radiation not more effective against Hodgkins lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Chemo Drug May Benefit Some Breast Cancer Patients
(Date:9/22/2014)... Mississauga, Ontario (PRWEB) September 22, 2014 ... August 1st, 2014 at the PWN International Conference in ... Canadian release that was celebrated with a reception attended ... this reception Dawn shared insights she had gained while ... organizational side of the glass ceiling issue, and what ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 Fancyflyingfox.com, the well-known ... collection of 2014 plus size wedding dresses . In ... offer for these fashionable plus size outfits. Each item in ... price, up to 65% off. , The company has ... of them are now available at extremely affordable prices. Its ...
(Date:9/21/2014)... September 22, 2014 CareSpan USA, Inc. ... entered into a joint services agreement with Avera eCARE, ... deploy the CareSpan Virtual Clinic in multiple states where ... plan to deploy their joint services in remote and ... where Avera eCARE is licensed. The two companies’ strategy ...
(Date:9/21/2014)... study of cancer patients who smoke, those using e-cigarettes ... and equally or less likely to have quit smoking ... Cancer , a peer-reviewed journal of the American Cancer ... of e-cigarettes for helping cancer patients give up smoking. ... cancer patients who smoke should be advised to quit. ...
(Date:9/21/2014)... of the leading online stores of real and synthetic hair ... human hair lace wigs inspired by 6 famous celebrities. It’s ... latest celebrity hairstyles are. , For people who ... to choose from: a style of yaki straight lace wig, ... ombre red lace wig. People can go to the product ...
Breaking Medicine News(10 mins):Health News:Ruby Report Book Launch Reveals Critical Insights on Gender Intelligence 2Health News:Discounted Plus Size Wedding Dresses Available At Fancyflyingfox.com 2Health News:Avera eCARE and CareSpan form Collaboration to Deliver “Virtualized” Primary Care in the Dakotas and Wyoming 2Health News:Avera eCARE and CareSpan form Collaboration to Deliver “Virtualized” Primary Care in the Dakotas and Wyoming 3Health News:E-cigarettes unhelpful in smoking cessation among cancer patients 2Health News:UniWigs New Arrivals Just In- Human Hair Lace Wigs Inspired By Famous Celebrities 2
... looking to benefit from the lucrative coaching market , ... Cincinnati (PRWEB) ... employee wellness market. Companies interested in exploiting this market opportunity face ... goal of controlling skyrocketing health insurance costs, a third of organizations already ...
... Space Shuttle delivered high-resolution video , ... Van Nuys, ... leader in high-quality lenses for industrial applications, has just announced that ... to play an important role in the recent servicing in orbit ...
... Metropolitan area physicians , ... Rye Brook, N.Y. (PRWEB) ... providers of specialized anatomic pathology services, today announced the opening of ... enhance services for Metropolitan area physicians. Licensed by the New York ...
... Federal And State Dollar Spent, 96 Cents Goes to Shovel ... Goes to Prevention and TreatmentWASHINGTON, May 28 ... at least $467.7 billion in 2005, according to Shoveling ... and Local Budgets, a new 287-page report released today ...
... Construction and Sleep Experts have been honored as ... Ethics Awards. Two area medical facilities, Texas Institute ... were among the nine finalists.The other 2009 finalists ... Aspire, Cadence McShane Construction Company and The Dwyer ...
... Texas; PHILADELPHIA The Lance Armstrong Foundation (LAF) ... to further develop and disseminate the LIVESTRONG Care ... service gives cancer survivors, their families and physicians ... care using up-to-date treatment information based on Institute ...
Cached Medicine News:Health News:Hummingbird Coaching's New White Paper on Health Coaching: Build it or Buy it? 2Health News:Hummingbird Coaching's New White Paper on Health Coaching: Build it or Buy it? 3Health News:Hubble Space Telescope Servicing In Orbit Monitored By Three Schneider Lenses 2Health News:Hubble Space Telescope Servicing In Orbit Monitored By Three Schneider Lenses 3Health News:CBLPath Opens Manhattan Facility 2Health News:New CASA* Report Finds Federal, State and Local Governments Spend Almost Half a Trillion Dollars a Year on Substance Abuse and Addiction 2Health News:New CASA* Report Finds Federal, State and Local Governments Spend Almost Half a Trillion Dollars a Year on Substance Abuse and Addiction 3Health News:New CASA* Report Finds Federal, State and Local Governments Spend Almost Half a Trillion Dollars a Year on Substance Abuse and Addiction 4Health News:New CASA* Report Finds Federal, State and Local Governments Spend Almost Half a Trillion Dollars a Year on Substance Abuse and Addiction 5Health News:Medical Facilities Among Finalists for Greater Dallas Business Ethics Awards 2Health News:LIVESTRONG and Penn Medicine announce partnership to bring online care plan tool to cancer survivors 2
(Date:9/19/2014)... CHESTER, Pa. , Sept. 19, 2014 /PRNewswire/ ... launched two new variable angle plating systems featuring ... technology, surgeons can adapt screw trajectory to match ... towards specific fragments of bone. The systems are ... Foot & Ankle Society (AOFAS) and the International ...
(Date:9/19/2014)... , Sept. 19, 2014 /PRNewswire-iReach/ -- ... to 2020″, provides key market data ... devices market. The report provides value, ... volume (in units) within market categories ... Sigmoidoscopes, Esophagoscopes & Gastroscopes, Duodenoscopes, Laparoscopes, ...
(Date:9/19/2014)... TRIANGLE PARK, N.C. , Sept. 19, 2014 ... focused on cloud-based drug design and development, partnering ... The company,s mission is to design new drugs ... 1 and 2 partners to further their development. ... its portfolio investments. To support this business model, ...
Breaking Medicine Technology:DePuy Synthes Proprietary Variable Angle Locking Technology Now Available To Treat Calcaneal Fractures And Medial Column Fusion Procedures 2DePuy Synthes Proprietary Variable Angle Locking Technology Now Available To Treat Calcaneal Fractures And Medial Column Fusion Procedures 3United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 2United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 3United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 4United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 5Cloud Pharmaceuticals Announces Partnering Sessions and Presentation Schedule 2
... N.J., June 8, 2011 Amerigen Pharmaceuticals Limited ... into a broad-based collaboration agreement regarding the development ... terms of the agreement, AustarPharma will use its ... Amerigen to commercialize in the United States and ...
... ATLANTA, June 8, 2011 Elekta has collaborated with ... NCCN Clinical Practice Guidelines in Oncology ( NCCN Guidelines ... offers Elekta users real-time access to NCCN,s evidence-based clinical ... " The NCCN Guidelines ...
Cached Medicine Technology:Amerigen Pharmaceuticals and AustarPharma Enter Into Collaboration Agreement for Generic Oral Controlled Release Products 2National Comprehensive Cancer Network Guidelines Available in Elekta's MOSAIQ EMR 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: